Get Ready, It’s Coming Next Week! What to Expect at COMPUTEX 2021
26.5.2021 10:36:00 EEST | Business Wire | Press release
COMPUTEX 2021 will be launched from May 31 to June 30. The organizer, the Taiwan External Trade Development Council (TAITRA), will roll out the #COMPUTEXVirtual platform to connect the technology community that breaks geographic limitations. COMPUTEX 2021 will offer an exceptional exhibition experience to attendees with the following highlights.
Highlight #1: Top Speakers Will Address on the Groundbreaking Technologies
COMPUTEX 2021 will kick off with the highly anticipated CEO Keynotes. From May 31 to June 2, key industry executives will discuss topics covering AI, high-performance computing (HPC), and other technology trends. Simon Segars, CEO of Arm, Dr. Lisa Su, President and CEO of AMD, Sanjay Mehrotra, President and CEO of Micron, Charles Liang, Founder, President and CEO of Supermicro, and Kurt Sievers, President and CEO of NXP Semiconductors are among the speaker lineup.
The COMPUTEX Forum on June 2 and 3 will revolve around the theme of "The New Era of Intelligence," focusing on key applications of AI, 5G, IoT, and electric vehicles. The forum will unlock the development of quantum computers and explore the infinite possibilities of future technology applications. The world's leading ICT experts will discuss business strategies and pulse industry trends in the post-pandemic era.
Highlight #2: Virtual Booths Will Showcase the Latest Products
#COMPUTEXVirtual, the all-new smart online platform, will use AI and automation technology to create an exceptional digital journey for users by providing a personalized interactive experience. Visitors will be able to obtain the latest product information in real-time.
Acer will showcase its very latest products and innovations that will be announced at its next@acer Global Press Conference to be held on May 27. It will also showcase solutions from its subsidiaries, including products for smart cities, AI, and enterprise use. ZOTAC, on the other hand, will be revealing a brilliant lineup of innovations, including the ZOTAC GAMING GeForce 3090 AMP Extreme Holo graphics card and the MAGNUS ONE ECM53060C mini PC.
Along with the big corporates, innovative startups are always the core elements to drive COMPUTEX and all the industry moving forward. The Epoch Foundation, committed to building partnerships in the global entrepreneurial community, has created a pavilion titled “Garage+ 46 Must-See Startups” on the #COMPUTEXVirtual platform. The exhibition is divided into three sections: “AI & Big Data,” “Digital Health & EdTech,” and “IoT & Energy.”
Moreover, #COMPUTEXVirtual builds #InnoVEXVirtual as a featured exhibit area to help startups connect with the international community. In addition to French Pavilion, Korean Pavilion, and the Dutch Pavilion, the European Bank for Reconstruction and Development (EBRD) is bringing 18 startups from 7 countries to join InnoVEX for the first time.
Highlight #3: Effective Online Platform Functions Will Synergize Matchmaking Opportunities
To maximize the benefits for exhibitors, #COMPUTEXVirtual will provide multiple effective, timely communication channels for exhibitors and visitors, such as video conferencing, meeting requests and instant messaging. Exhibitors can use AI technology to identify target audiences and promote products. Hyper-Personalized Recommendations will also help increase the matchmaking accuracy and enable companies to seize business opportunities effectively.
Together with the technology giants and disruptive startups, COMPUTEX 2021 is ready to bring the world an all-new digital experience. For more exhibition information, please visit the following:
- #COMPUTEXVirtual Online Exhibition Visitor Registration: https://virtual.computextaipei.com.tw/
- COMPUTEX CEO Keynote and COMPUTEX Forum Registration: https://virtual.computextaipei.com.tw/events/
About COMPUTEX TAIPEI (also called COMPUTEX):
Established in 1981, COMPUTEX is one of the leading global ICT, IoT, and startup tradeshows with a complete supply chain and IoT ecosystems. Co-organized by the Taiwan External Trade Development Council (TAITRA) and Taipei Computer Association (TCA), COMPUTEX, based upon Taiwan’s complete ICT clusters, covers the whole spectrum of the ICT industry, from established brands to startups and from ICT supply chain to IoT ecosystems. With strong R&D and manufacturing capabilities and IPR protection, Taiwan is a strategic destination for foreign companies and investors looking for partners in global technology ecosystems. Follow COMPUTEX on its website at www.computextaipei.com.tw and Twitter @computex_taipei using the hashtag #COMPUTEX.
About COMPUTEX 2021 Virtual:
As a pioneer in technology, COMPUTEX has been at the forefront in embracing digital transformation. In 2021, the show will go online. Together with the key global technology players, the organizer of COMPUTEX,Taiwan External Trade Development Council (TAITRA) introduces #COMPUTEXVirtual (including its global startups and innovations showcase #InnoVEXVirtual), an AI-driven virtual platform, and aims to deliver an exceptional virtual exhibition experience beyond the distance.
About TAITRA:
Founded in 1970, TAITRA is Taiwan's foremost nonprofit trade promoting organization. Sponsored by the government and industry organizations, TAITRA assists enterprises to expand their global reach. Headquartered in Taipei, TAITRA has a team of 1,300 specialists and operates 5 local offices in Taoyuan, Hsinchu, Taichung, Tainan and Kaohsiung, as well as 63 branches worldwide. Together with Taipei World Trade Center (TWTC) and Taiwan Trade Center (TTC), TAITRA has formed a global network dedicated to promoting world trade.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20210526005459/en/
Contact information
For more updates：
COMPUTEX website: https://www.computextaipei.com.tw/
InnoVEX website : https://www.innovex.com.tw/
Press Contacts:
Ms. Tessa Lin <tessalin@taitra.org.tw
Ms. Li Chao < lichao@taitra.org.tw
About Business Wire
For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Wyss Geneva Steps Into Its Next Chapter11.6.2026 14:33:00 EEST | Press release
The Wyss Center for Bio and Neuroengineering in Geneva is pleased to announce the appointment of Dr. Tracy Laabs as Director, effective July 1st 2026. Dr. Laabs succeeds Prof. Dr. Erwin Böttinger, who leaves behind a fundamentally transformed organization: one that no longer just pursues breakthrough science but systematically turns it into ventures that reach patients. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260611328520/en/ Dr. Tracy Laabs, incoming Director, Wyss Center Geneva Since joining the Wyss Center as Director in April 2023, Prof. Böttinger brought a bold vision: to evolve the Center from a portfolio of promising projects into a disciplined engine for venture creation. Under his leadership, the Center spun off six companies in two years (including ABILITY Neurotech SA and Clee Medical SA in 2025) while simultaneously building a robust pipeline of next-generation programs in AI-guided neuromodulation and min
BeOne Showcases Landmark Phase 3 Data in CLL Patients Aged 80+ at EHA 2026, Reinforcing BRUKINSA Benefit11.6.2026 14:24:00 EEST | Press release
BeOne Medicines Ltd. (Nasdaq: ONC; HKEX: 06160; SSE: 688235), a global oncology company, today announced the presentation of a large Phase 3 dataset in patients with chronic lymphocytic leukemia or small lymphocytic lymphoma (CLL/SLL) aged 80 and older, showing sustained benefit with BRUKINSA after nearly 6.5 years of follow-up, reinforcing its role as the foundational BTK inhibitor. BRUKINSA is the only BTK inhibitor to demonstrate superior efficacy vs. ibrutinib in a Phase 3 trial.1 These data, one of the largest datasets of older patients with treatment-naive CLL, will be presented at the 2026 European Hematology Association (EHA) Congress in Stockholm, Sweden. Amit Agarwal, M.D., Ph.D., Chief Medical Officer, Hematology, BeOne Medicines, said: "While the median age of diagnosis for CLL is 70 and the average age of treatment initiation is 75, many pivotal trials still underrepresent the patients that physicians most often see in practice. These data show that the durable benefit of
Clearlake Expands Liquid Credit Platform With Acquisition of LCM Asset Management’s CLO Contracts11.6.2026 14:00:00 EEST | Press release
Clearlake Capital Group, L.P. (“Clearlake” or the “Firm”), a global investment firm managing integrated platforms spanning private equity, liquid and private credit, and other related strategies, today announced that its credit platform, Clearlake Credit, will assume management of CLOs managed by LCM Asset Management, LLC. The transaction adds 31 CLOs representing more than $5 billion of assets under management and increases assets managed by Clearlake Credit to approximately $39 billion across liquid credit, private credit, and other customized credit solutions. The acquisition further broadens the Firm’s capabilities, deepens its relationships with institutional investors, and reinforces its client-centric approach and commitment to seeking attractive risk-adjusted returns across market cycles. Milbank LLP and Dechert LLP represented Clearlake Credit in the transaction. GreensLedge Capital Markets advised the seller. About Clearlake Clearlake Capital is a leading global alternative a
Takeda’s Zasocitinib Significantly Outperforms Deucravacitinib in Head-to-Head Phase 3 Psoriasis Study, Promising to Redefine Oral Treatment Expectations11.6.2026 14:00:00 EEST | Press release
Takeda (TSE:4502/NYSE:TAK) announced positive topline results for the Phase 3, randomized, multicenter, double-blind study comparing zasocitinib (TAK-279), an investigational, next-generation, highly selective and potent oral tyrosine kinase 2 (TYK2) inhibitor, to deucravacitinib in adults with moderate-to-severe plaque psoriasis (PsO). In the LATITUDE Atlas (TAK-279-PsO-3004) head-to-head study, zasocitinib demonstrated statistical superiority over deucravacitinib for the primary endpoint, Psoriasis Area and Severity Index (PASI) 100 response rate at week 16. The study also demonstrated statistical superiority over deucravacitinib for all key secondary endpoints, including PASI 90 response and Static Physician's Global Assessment (sPGA) 0 at week 16. Zasocitinib was generally well tolerated with a consistent safety and tolerability profile and no new safety signals identified. Perspectives on head-to-head zasocitinib study “In this head-to-head study, zasocitinib clearly demonstrated
L&T Technology Services, Databricks Partner to Deliver Industrial AI at Scale for Asset-Intensive Industries11.6.2026 13:30:00 EEST | Press release
L&T Technology Services (BSE: 540115, NSE: LTTS), a global leader in AI, Digital & ER&D Consulting Services, today announced a strategic go-to-market partnership with Databricks, the leading Data and AI company, to co-develop and deliver Industrial AI solutions that advance Engineering Intelligence (EI) for asset-intensive enterprises. Anchored in LTTS' Sustainability segment, spanning Process Engineering, Discrete Manufacturing and Industrial Products, the partnership will support Energy, Petrochemicals and Industrials clients globally. As industrial organizations seek to unlock greater value from decades of operational and engineering data, the alliance will combine LTTS’ deep domain capabilities with the Databricks platform to transform complex plant data into Engineering Intelligence - enabling improved asset reliability, operational efficiency and sustainability performance. The partnership brings together LTTS’ expertise in forward looking technologies and extensive experience ac
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom